Humana Inc.’s stock slid another 2.5% Thursday to bring its week-to-date losses to 24.4%, after BofA Securities downgraded it to underperform — or sell — on concerns about a delay in margin recovery.

The health insurer has lost 24% in the week to data after it said the government is set to cut the rating on a large Medicare ...

Humana (HUM) stock fell as Piper Sandler cut rating due to a sharp drop in top-rated Medicare plan enrollments that led to a ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

Humana's stock took a tumble after the provider admitted to the SEC that only about 1 in 4 of its members were signed up to Medicare Advantage plans rated four stars or more. Meanwhile, CMS is making ...

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Baxter from ...

Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...

The S&P 500 finished virtually unchanged, a day after sliding from its record on worries about a possible widening of the ...

The stock slid more than 10% as the health insurer warned that a steep drop in the federal government’s quality ratings of ...

As the stock market reached record highs in the third quarter, most of the public companies headquartered in the Jacksonville ...

U.S. stocks edged higher on Wednesday, and Treasury yields rose following an encouraging update on the job market’s strength.

The insurer said the share of its customers currently enrolled in plans rated four stars or higher for 2025 is down to 25% ...